PRESTRELSKI STEVEN

Track

Insider profile

PRESTRELSKI STEVEN's trades of Xeris Biopharma Holdings Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-02-24 2022-02-22
PlS Planned sale
5,788 +4.9%
402.41
US$4,611,191 		5,788 +4.9% 402.41 US$4,611,191
2021-01-15 2021-01-13
PlS Planned sale
47,053 -16.9%
91.42
US$2,818,856 		47,053 -16.9% 91.42 US$2,818,856
2021-01-12 2021-01-11
PlS Planned sale
85,695 -2.1%
61.20
US$1,984,103 		85,695 -2.1% 61.20 US$1,984,103
2020-01-14 2020-01-13
PlS Planned sale
10,000 -2.3%
5.50
US$54,992 		10,000 -2.3% 5.50 US$54,992
2019-10-16 2019-10-11
PlS Planned sale
10,000 -2.2%
7.97
US$79,746 		10,000 -2.2% 7.97 US$79,746
2019-10-16 2019-07-11
PlS Planned sale
38 -0.0%
12.70
US$483 		38 -0.0% 12.70 US$483
2019-10-16 2019-07-11
PlS Planned sale
9,962 -2.1%
12.04
US$119,913 		9,962 -2.1% 12.04 US$119,913
2019-04-12 2019-04-11
PlS Planned sale
10,000 -2.1%
9.56
US$95,649 		10,000 -2.1% 9.56 US$95,649
2019-10-16 2019-01-14
PlS Planned sale
7,700 -1.6%
17.20
US$132,459 		7,700 -1.6% 17.20 US$132,459
2019-01-15 2019-01-11
PlS Planned sale
2,300
0.00
US$0 		2,300 0.00 US$0
2019-01-02 2018-12-26
S Sale
15,720 -3.1%
15.82
US$248,738 		15,720 -3.1% 15.82 US$248,738